Effectiveness of sectral (M and B 17803A) as a beta-blocking agent in man
Lewis, B.S.; Bakst, A.; Kitchiner, D.; Gotsman, M.S.
South African Medical Journal 47(27): 1181-1184
1973
ISSN/ISBN: 0256-9574 PMID: 4146564 Document Number: 64287
Document emailed within 1 workday
Related Documents
De Ponti, C.; Mauri, F.; Fiorista, F.; Ciliberto, G.R.; Carù, B.; Rovelli, F. 1977: Effectiveness of nifedipine on exercise tolerance in patients with angina pectoris. Comparison with a nitroderivative and a beta-blocking agent Giornale Italiano di Cardiologia 7(12): 1162-1171Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Naess, K. 1973: A beta blocking agent as an antihypertensive agent Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(27): 2041
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Lindner, E. 1984: L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity Arzneimittel-Forschung 34(3): 270-276
Dal Palu, C. 1971: Sudden death during treatment by beta-blocking agent Annales de Cardiologie et d'Angeiologie 20(1): 69-70
Ishii, M.; Komori, S.; Satoh, H.; Ohta, T.; Motomura, S.; Hashimoto, K. 1984: Effects of N-696, a new beta-blocking agent, on canine experimental arrhythmias Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 84(3): 259-266
Hansson, L.; Henningsen, N.C.; Jameson, S.; Karlberg, B.E.; Westerlund, A.; Aberg, H. 1976: Clinical testing of a new beta blocking agent--atenolol--in hypertension Lakartidningen 73(34): 2741-2744
Guechot, C.; Bertrand, A.; Cramaille, P.; Teulon, J.M. 1988: Analytical profile of the new diuretic beta-blocking agent tienoxolol hydrochloride Arzneimittel-Forschung 38(5): 655-660
Salmini, G.; Cione, R.; Oldrini, R. 1970: Clinical evaluation of the therapeutic action of a beta-blocking agent associated with a nitroderivative Minerva Cardioangiologica 18(5): 311-315
Di Veroli, C.; Compagno, S. 1982: Clinical evaluation of a beta-blocking agent in a single daily dose La Clinica Terapeutica 101(6): 623-628
Neviani, V.; Tosi, P.; Prampolini, M.L. 1976: 1st experiences with the clinical use of a new beta-blocking agent (tolamolol) in some heart diseases La Clinica Terapeutica 77(5): 451-458
Bricaire, H.; Pandos 1971: Clinical study on the action of a beta blocking agent (LB 46) on some manifestations of hyperthyroidism and hypothyroidism La Presse Medicale 79(51): 2301-2304
Hamilton, T.C.; Parkes, M.W. 1977: Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology Arzneimittel-Forschung 27(7): 1410-1417
Kirch, W.; Von Gizycki, C. 1980: Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances International Journal of Clinical Pharmacology Therapy and Toxicology 18(5): 233-235
Baïsset, A.; Dang-Tran, L.; Montastruc, P. 1971: Effect of an adrenergic beta-blocking agent on adrenaline-induced hyperglycemia in hypophysectomized dogs Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(11): 2209-2214
Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98
Lehner, J.P.; Simon, A.; Kehder, A.; Weiss, Y.; Tzincoca, C.; Safar, M. 1978: Evaluation of cardiac performance in the hypertensive patient. Effect of a beta-blocking agent: atenolol Archives des Maladies du Coeur et des Vaisseaux 71(10): 1107-1112
Dufour, R.; Scazziga, B.; Schelling, J.L. 1970: Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(1): 145-147